SCYNEXIS INC (SCYX) Form 8-K Material Events
SCYNEXIS INC (SCYX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SCYX
CIK: 1178253
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerMichael Makovec
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-28 | 2026-09-25 | 8-K | 0001178253-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 | 0001193125-26-397873 | View SEC Doc Filr Page |
| 3 | 2026-09-22 | 2026-09-18 | 3 | 0001193125-26-397869 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-18 | 8-K | 0001178253-26-000035 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | 4 | 0001790246-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-09-11 | 2026-09-09 | 3 | 0001790246-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-09 | 8-K | 0001178253-26-000031 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001649553-26-000108 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003532 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-12 | — | SCHEDULE 13G Filing | 0000919574-26-004987 | View SEC Doc Filr Page |
| S-8 | 2026-08-10 | — | S-8 | 0001178253-26-000029 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001178253-26-000027 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-20 | — | SCHEDULE 13G/A Filing | 0001623632-26-001029 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001623632-26-000992 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | 4 | 0001797160-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | 4 | 0001296998-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | 4 | 0001219866-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | 4 | 0001237401-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | 4 | 0001286338-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-25 | 8-K | 0001178253-26-000021 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-28 | 8-K | 0001178253-26-000017 | View SEC Doc Filr Page |
| 8-K | 2026-05-22 | 2026-05-19 | 8-K | 0001178253-26-000014 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001649553-26-000059 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001178253-26-000011 | View SEC Doc Filr Page |
| EFFECT | 2026-05-08 | — | EFFECT Filing | 9999999995-26-001563 | View SEC Doc Filr Page |